Chemical Compound
cefpodoxime proxetil
CAS Registry Number
87239-81-4
Primary Record
cefpodoxime proxetil
- In stock
- 603 g
- Purity
- 99.8 %
- CAS
- 87239-81-4
Compound Identifiers & Properties
- CAS
- 87239-81-4
- PubChem CID
- 6526396
- SMILES
- CC(C)OC(=O)OC(C)OC(=O)C1=C(CS[C@H]2N1C(=O)[C@H]2NC(=O)/C(=N\OC)/C3=CSC(=N3)N)COC
- Canonical SMILES
- COCC1=C(C(=O)OC(C)OC(=O)OC(C)C)N2C(=O)[C@@H](NC(=O)/C(=N\OC)c3csc(N)n3)[C@H]2SC1
Names & Synonyms
- cefpodoxime proxetil
- Vantin
- Banan
- Orelox
- Otreon
- Simplicef
- Cefodox
- Doxef
- Podomexef
- Cefoprox
- Cepodem
- 87239-81-4
- Cefpoderm
- Vanacefan
- Sepoxym
- Cefpodoxime acid
- Orelox Paed
- Xtum-O
- Cefodoxime Proxetil
- Vanacefan-DS
- cephalosporin 807
- Cefpodoximeproxetil
- Cephpodoxime Proxetil
- Proxetil, Cefpodoxime
- 807, Cephalosporin
- Antibiotic CS 807
- CS-807
- Simplicef [Veterinary]
- Vantin (TN)
- CEFPODOXIME
- Antibiotic CS-807
- Cefpodoxime Proxetil RS
- RefChem:56373
- Cefpodoxime proxetil CRS
- AC1O6HBL
- 2TB00A1Z7N
- CHEBI:3505
- CS-807(pharmaceutical)
- UNII-2TB00A1Z7N
- DTXSID1022766
- MFCD00865088
- U-76252
- C21H27N5O9S2
- DTXCID802766
- SCHEMBL27071
- MLS001401428
- CS 807
- orb1302381
- Cefpodoxime Proxetil (Standard)
- CHEMBL1201016
- NSC-759161
- ERK5-3O22
- HY-N7101R
- CEFPODOXIME (AS PROXETIL)
- Cefpodoxime proxetil [USAN:JAN]
- LTINZAODLRIQIX-FBXRGJNPSA-N
- Cefpodoxime proxetil (JP18/USP)
- CEFPODOXIME PROXETIL [JAN]
- GLXC-23147
- HMS3715J22
- Cefpodoxime proxetil [USAN:USP:JAN]
- CEFPODOXIME PROXETIL [USAN]
- 807, CS
- CEFPODOXIME PROXETIL, VANTIN
- HY-N7101
- CEFPODOXIME PROXETIL [VANDF]
- Tox21_113377
- Tox21_113428
- BBF-00739
- BDBM50248233
- CEFPODOXIME PROXETIL [MART.]
- MSK162941
- s5350
- CEFPODOXIME PROXETIL [USP-RS]
- CEFPODOXIME PROXETIL [WHO-DD]
- AKOS015994692
- AN-7622
- C21-H27-N5-O9-S2
- CCG-221250
- CID6526396
- FC19867
- KS-1149
- NSC 759161
- CID:6526396
- CEFPODOXIME PROXETIL [GREEN BOOK]
- NCGC00164598-01
- NCGC00183131-01
- CEFPODOXIME PROXETIL [ORANGE BOOK]
- CPD000469193
- RU 51807
- RU-51807
- SAM001246674
- SMR000469193
- SY271316
- U 76252
- CEFPODOXIME PROXETIL [EP MONOGRAPH]
- CEFPODOXIME PROXETIL [USP IMPURITY]
- SID:488951926
- U76252
- CAS-87239-81-4
- CEFPODOXIME PROXETIL [USP MONOGRAPH]
- Cefpodoxime proxetil for peak identification
- J227.713A
- cefpodoxime 1-(isopropyloxycarbonyloxy)ethyl ester
- CS-0027614
- 76252, U
- C08115
- D00920
- H11930
- AB01209734-01
- Cefpodoxime proxetil for peak identification CRS
- 239C814
- A842048
- C053267
- Cefpodoxime proxetil for impurity H identification
- (RS)-1-((Isopropoxycarbonyl)oxy)ethyl (+)-(6R,7R)-7-(2-(2-amino-4-thiazolyl)-2-((Z)-methoxyimino)acetamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
- Q1052672
- U-76,252
- BRD-A34205213-001-03-9
- Cefpodoxime proxetil for impurity H identification CRS
- L-(-)-Di-1,4-O-benzoyl-L-tartaric acid monohydrate
- (6R,7R)-1-((Isopropoxycarbonyl)oxy)ethyl 7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- CEFPODOXIME 1-(ISOPROPOXYCARBONYLOXY)ETHYL ESTER
- D000097627
- CEFPODOXIME 1-(ISOPROPOXYCARBONYLOXY)ETHYL ESTER [MI]
- (+-)-1-Hydroxyethyl (+)-(6R,7R)-7-(2-(2-amino-4-thiazolyl)glyoxylamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7(sup 2)-(Z)-(O-methyloxime), isopropyl carbonate (ester)
- 1-((Isopropoxycarbonyl)oxy)ethyl (6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- 1-(isopropoxycarbonyloxy)ethyl-7-(2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetamido)-3-methoxymethyl-8-oxo-5-thia-1-azabicyclo(4,2,0)-oct-2-ene-2-carboxylate
- 1-{[(propan-2-yloxy)carbonyl]oxy}ethyl (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- 1-{[(propan-2-yloxy)carbonyl]oxy}ethyl 7beta-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-(methoxymethyl)-3,4-didehydrocepham-4-carboxylate
- 1-propan-2-yloxycarbonyloxyethyl (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-, 1-(((1-methylethoxy)carbonyl)oxy)ethyl ester, (6R-(6alpha,7beta(Z)))-
- (+/-)-1-HYDROXYETHYL (+)-(6R,7R)-7-(2-(2-AMINO-4-THIAZOLYL)GLYOXYLAMIDO)-3-(METHOXYMETHYL)-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLATE, 7 (SUP 2)-(Z)-(O-METHYLOXIME), ISOPROPYL CARBONATE (ESTER)
- (1RS)-1-((1-Methylethoxy)carbonyloxy)ethyl (6R,7R)-7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetylamino)-3-methoxymethyl-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
- (6R,6beta)-7alpha-[[(2-Aminothiazol-4-yl)[(Z)-(methoxy)imino]acetyl]amino]-3-methoxymethyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 1-(isopropoxycarbonyloxy)ethyl ester
- (6R,7R)-7-(((2Z)-2-(2-AMINO-4-THIAZOLYL)-2-(METHOXYIMINO)ACETYL)AMINO)-3-(METHOXYMETHYL)-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID 1-(((1-METHYLETHOXY)CARBONYL)OXY)ETHYL ESTER
- (6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2 -carboxylic Acid 1-[[(1-Methylethoxy)carbonyl]oxy]ethyl Ester
- (6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid 1-[[(1-Methylethoxy)carbonyl]oxy]ethyl Ester
- (6R,7R)-7alpha-[[(2-Amino-4-thiazolyl)[(Z)-methoxyimino]acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 1-[[(1-methylethoxy)carbonyl]oxy]ethyl ester
- (RS)-1(ISOPROPOXYCARBONYLOXY)ETHYL(+)-(6R,7R)-7-[2-(2-AMINO-4-THIAZOLYL)-2-[(Z)METHOXYIMINO]ACETAMIDO]-3-METHOXYMETHYL-8-OXO-5-TChemicalbookHIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLATE
- 1-(((propan-2-yloxy)carbonyl)oxy)ethyl (6R,7R)-7-(((2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl)amino)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate;1-(((propan-2-yloxy)carbonyl)oxy)ethyl 7beta-((2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido)-3-(methoxymethyl)-3,4-didehydrocepham-4-carboxylate
- 1-({[(1-methylethyl)oxy]carbonyl}oxy)ethyl (6R,7R)-7-({(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(methyloxy)imino]acetyl}amino)-3-[(methyloxy)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- 1-({[(Propan-2-yl)oxy]carbonyl}oxy)ethyl (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- 1-{[(propan-2-yloxy)carbonyl]oxy}ethyl (6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamido]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- 1-isopropoxycarbonyloxyethyl (6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- 1-propan-2-yloxycarbonyloxyethyl (6R,7R)-7-(((2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl)amino)-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
- 1-propan-2-yloxycarbonyloxyethyl (6R,7R)-7-[[(2Z)-2-(2-azanyl-1,3-thiazol-4-yl)-2-methoxyimino-ethanoyl]amino]-3-(methoxymethyl)-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-(((2-AMINO-4-THIAZOLYL)(METHOXYIMINO)ACETYL)AMINO)-3-(METHOXYMETHYL)-8-OXO-, 1-(((1-METHYLETHOXY)CARBONYL)OXY)ETHYL ESTER, (6R-(6.ALPHA.,7.BETA.(Z)))-
- 947692-13-9
- Cefpodoxime proxetil; (1RS)-1-[[(1-Methylethoxy)carbonyl]oxy]ethyl (6R,7R)-7-[[(2Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate